September 21-22, 2017
FDA CFSAN Building
5001 Campus Drive
College Park, Md
Plenary session, Day 1
Topic: Alternatives to acute systemic toxicity
Speakers: Anna Lowit, US EPA OPP & Dan Wilson, Dow Chemical Company
Plenary session, Day 2
Topic: Lautenberg Chemical Safety Act (LCSA) implementation
Speaker: Louis “Gino” Scarano, US EPA OPPT
Oral Presentation Abstract Deadline: July 1, 2017
In recent months a particular focus has been paid to replacing in vivo tests for acute systemic toxicity endpoints, and the first session of this meeting will focus on these efforts, with plenary speakers providing an overview of multi-stakeholder working group efforts to advance science and policy to make progress. Submitted abstracts relevant to methods or approaches for acute systemic toxicity will be considered for oral presentations for this Thursday morning session.
Under the Lautenberg Chemical Safety Act (LCSA), the EPA is tasked with creating a strategic plan for developing and implementing methods which reduce and replace vertebrate animal testing. The meeting’s Friday morning session will provide a forum for discussion amongst the stakeholder community and with EPA. After Dr. Scarano’s presentation, ample time will be allowed for an active exchange of views.
In this session, the program committee also wishes to highlight in vitro or computational toxicology methods or approaches which may provide information on the medium- or long-term systemic toxicity of industrial chemicals, and may include endpoints such as repeated-dose inhalation toxicity, carcinogenesis, toxicokinetics, and reproductive or developmental toxicity. Such methods and approaches will be needed to allow the assessment of thousands of new and existing chemicals and significantly reduce and replace vertebrate animal tests under the LCSA, and abstracts focusing on these topics will be considered for talks in this Friday morning session.
Abstracts presenting work on any other topics related to in vitro and computational toxicology are welcome and will be considered for oral or poster presentations outside of these two morning sessions.
As in past years, the meeting will also include a poster session, mentoring and networking opportunities, and a reception and awards ceremony.
Abstracts are requested on all topics related to cellular and computational toxicology. To be considered for an oral presentation, abstracts must be submitted before July 1, 2017. Poster-only abstracts may be accepted up to the meeting depending on space. Authors should indicate whether they would like to be considered for an oral or poster presentation, and whether they consider their abstract as fitting into one of the special sessions (i.e., acute systemic toxicity or advancing chemical safety under the LCSA).
To submit your abstract, please email it to firstname.lastname@example.org with the subject line “ASCCT abstract”. Abstracts should be submitted as Microsoft Word documents according to this template and no more than 250 words. Submitting author’s email address must be included in the abstract.
- Abstract submission deadline: July 1
- Author notification: August 1
As in previous years, the ASCCT will offer the Edward Carney Award for Predictive Toxicology and the Tox21 Student Award for the best presentations; entries in the form of full poster or slide presentations must be received by September 18th and should be sent to Kristie Sullivan. Winners of each award will receive a $500 prize.
A mentoring event will be held during the meeting to provide young and career scientists in computational and in vitro toxicology the opportunity to network and engage with each other. If you are interested in being involved, please indicate your interest when you register.
Registration and logistical information, and a draft program will be available shortly.
Sponsorship and partnering opportunities available; please contact Ellen Berg for more information.